SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oncothyreon
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
2344 74 0 ONTY
Emcee:  John Curtis Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2294I can keep posting this stuff until we all get sick of it (but I'm going to scaram(o)uche-9/6/2013
2293Got a clue, Dr. Kirkman??..... Shock. 2013 Aug 28. [Epub ahead of print] The Iscaram(o)uche19/6/2013
2292J Immunol. 2013 Aug 30. [Epub ahead of print] Exacerbation of Allergen-Induced scaram(o)uche-9/6/2013
2291Kirkman is on his way home/out??!!....... <i>Oncothyreon Announces Appoinscaram(o)uche-9/6/2013
2290Clin Vaccine Immunol. 2013 Aug 28. [Epub ahead of print] Enhancement of Serum ascaram(o)uche-9/4/2013
2289But what does it mean without a mechanism? If they have data showing that Red isClarksterh-8/30/2013
2288re. the SPRINT/rectal study.... same message as the concomitant immunity discscaram(o)uche-8/30/2013
2287AZN, a new player who will also be looking to pair vaccines with an anti-PD-1...scaram(o)uche-8/29/2013
2286Sorry for the duplicate post. IE now has an autocorrect function that doesn'scaram(o)uche-8/29/2013
2285>> Novartis appears to have chosen a subset of NSCLC as first 120 focus &lscaram(o)uche-8/29/2013
2284>> Novartis appears to have chosen a subset of NSCLC as first 120 focus &lscaram(o)uche-8/29/2013
2283>> otherwise Merck would have designed the trial to exclude sCRT << scaram(o)uche-8/29/2013
2282>> Dr. Butts is convinced that the c-CRT results are not false << Iscaram(o)uche-8/29/2013
2281New theory as to why s-CRT with blp-25 survival vs c-CRT with blp-25 was so diffNonos-8/25/2013
2280You asked for ideas, so I pointed to a ref. that I thought might help. I'vhirogen-8/25/2013
2279Just cited a paper from Dr. Jaffee's lab, and earlier mentioned Dr. Matzingescaram(o)uche-8/25/2013
2278Dr. Butts is convinced that the c-CRT results are not false (but of course he woNonos-8/25/2013
2277Rick and the author of the following study bring up the possibility that the posNonos-8/25/2013
2276Jim: Cyclophosphamide... don't know. I'd say that it looks obvious scaram(o)uche-8/25/2013
2275Thanks Rick for your reply. Enjoy your break. Curious as to why another CPA boNonos-8/25/2013
2274Hey, thanks. Good of you to dig up supporting/discounting stuff. I remember thscaram(o)uche-8/25/2013
2273The perplexing and intricate secret formula for control of nsclc The latest resuNonos-8/25/2013
2272Given that Red's thesis is the one that I understand best, I've tried toscaram(o)uche-8/25/2013
2271Thanks, Hiro. Nice to see you here, please add your stuff. >> by applyinscaram(o)uche-8/25/2013
2270That is, Dr. Wurz et al. might have predicted the shift in shape of the cCRT cuhirogen-8/25/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News